After-Hours Movers 06/22: (SCS) (BMY) (MLHR) Higher; (EXL) (PLD) (AGNC) Lower
Tweet
Share
E-mail
Get Alerts SCS Hot Sheet
Join SI Premium – FREE
Steelcase Inc. (NYSE: SCS) 5.7% HIGHER; reported Q1 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $639.4 million versus the consensus estimate of $589.33 million. Steelcase Inc. sees Q2 2011 EPS of $0.06-$0.10 (includes restructuring costs of about 9 cents per share), versus the consensus of $0.12. Steelcase Inc. sees Q2 2011 revenue of $670-$695 million, versus the consensus of $634.07 million.
Bristol-Myers Squibb Company (NYSE: BMY) 5.7% HIGHER; and Pfizer Inc. report topline results of the Phase 3 ARISTOTLE trial of ELIQUIS. In this study of patients with atrial fibrillation and at least one additional risk factor for stroke, ELIQUIS met the primary efficacy objective of non-inferiority to warfarin on the combined outcome of stroke (ischemic, hemorrhagic or unspecified type) and systemic embolism. In addition, ELIQUIS met the key secondary endpoints of superiority on efficacy and on ISTH (International Society on Thrombosis and Haemostasis) major bleeding compared to warfarin.
Excel Trust, Inc. (NYSE: EXL) 4.6% LOWER; announces a 12.5 million common follow-on offering. The Company has granted to the underwriters an option to purchase up to an additional 1.875 million shares within thirty days after the offering to cover over-allotments, if any
Herman Miller, Inc. (NASDAQ: MLHR) 3.5% HIGHER; reported Q4 EPS of $0.30, $0.04 better than the analyst estimate of $0.26. Revenue for the quarter came in at $441.5 million versus the consensus estimate of $417.98 million.
Red Hat, Inc. (NYSE: RHT) 3.4% HIGHER; reported Q1 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $264.7 million versus the consensus estimate of $253.58 million. Sees Q2 adj-EPS of 24-25c, vs. the consensus of 23c, sees sales of $270-$272 million, which compares to the Street estimate of $260.71 million, sees operating margin of 25.4-25.6%, sees FY12 adj-EPS of $0.98-$1, vs. the consensus of $0.96, raises sales guidance from $1.05-$1.07 billion to $1.07-$1.85 billion, vs. the consensus of $1.07 billion.
Prologis, Inc. (NYSE: PLD) 3.1% LOWER; announces a 30 million common stock offering.
Sonic Corp. (NASDAQ: SONC) 2.5% HIGHER; reported Q3 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $152.1 million versus the consensus estimate of $150.53 million. Comps up 3.9%.
Pfizer (NYSE: PFE) 2.3% HIGHER; see Bristol-Myers.
Bed Bath & Beyond, Inc. (NASDAQ: BBBY) 2.1% HIGHER; reported Q1 EPS of $0.72, $0.09 better than the analyst estimate of $0.63. Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2.08 billion. Bed Bath & Beyond, Inc. sees Q2 2011 EPS of $0.77-$0.82, versus the consensus of $0.82. Bed Bath & Beyond raises FY11 EPS to up 15-20 percent, from 10-15 percent.
American Capital Agency Corp. (Nasdaq: AGNC) 1.9% LOWER; announces a 36 million common stock offering. In connection with the offering, the Company intends to grant the underwriters an option for 30 days to purchase up to an additional 5,400,000 shares of common stock to cover overallotments, if any.
Phoenix New Media (NYSE: FENG) 1.6% HIGHER; reported Q1 EPS of ($1.97. Revenue for the quarter came in at $26.2 million. For the second quarter of 2011, the Company expects its net advertising revenues to be between RMB110 million to RMB112 million, which represents growth of approximately 142% to 146% from the second quarter of 2010. Paid service revenues are expected to be between RMB106 million to RMB109 million, which represents 35% to 39% growth from the second quarter of 2010. As a result, total revenues are expected to be between RMB216 million to RMB221 million, which represents 74% to 78% growth, approximately, from the second quarter of 2010.
Check out our After-Hours Movers entity page to track this report each day.
Bristol-Myers Squibb Company (NYSE: BMY) 5.7% HIGHER; and Pfizer Inc. report topline results of the Phase 3 ARISTOTLE trial of ELIQUIS. In this study of patients with atrial fibrillation and at least one additional risk factor for stroke, ELIQUIS met the primary efficacy objective of non-inferiority to warfarin on the combined outcome of stroke (ischemic, hemorrhagic or unspecified type) and systemic embolism. In addition, ELIQUIS met the key secondary endpoints of superiority on efficacy and on ISTH (International Society on Thrombosis and Haemostasis) major bleeding compared to warfarin.
Excel Trust, Inc. (NYSE: EXL) 4.6% LOWER; announces a 12.5 million common follow-on offering. The Company has granted to the underwriters an option to purchase up to an additional 1.875 million shares within thirty days after the offering to cover over-allotments, if any
Herman Miller, Inc. (NASDAQ: MLHR) 3.5% HIGHER; reported Q4 EPS of $0.30, $0.04 better than the analyst estimate of $0.26. Revenue for the quarter came in at $441.5 million versus the consensus estimate of $417.98 million.
Red Hat, Inc. (NYSE: RHT) 3.4% HIGHER; reported Q1 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $264.7 million versus the consensus estimate of $253.58 million. Sees Q2 adj-EPS of 24-25c, vs. the consensus of 23c, sees sales of $270-$272 million, which compares to the Street estimate of $260.71 million, sees operating margin of 25.4-25.6%, sees FY12 adj-EPS of $0.98-$1, vs. the consensus of $0.96, raises sales guidance from $1.05-$1.07 billion to $1.07-$1.85 billion, vs. the consensus of $1.07 billion.
Prologis, Inc. (NYSE: PLD) 3.1% LOWER; announces a 30 million common stock offering.
Sonic Corp. (NASDAQ: SONC) 2.5% HIGHER; reported Q3 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $152.1 million versus the consensus estimate of $150.53 million. Comps up 3.9%.
Pfizer (NYSE: PFE) 2.3% HIGHER; see Bristol-Myers.
Bed Bath & Beyond, Inc. (NASDAQ: BBBY) 2.1% HIGHER; reported Q1 EPS of $0.72, $0.09 better than the analyst estimate of $0.63. Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2.08 billion. Bed Bath & Beyond, Inc. sees Q2 2011 EPS of $0.77-$0.82, versus the consensus of $0.82. Bed Bath & Beyond raises FY11 EPS to up 15-20 percent, from 10-15 percent.
American Capital Agency Corp. (Nasdaq: AGNC) 1.9% LOWER; announces a 36 million common stock offering. In connection with the offering, the Company intends to grant the underwriters an option for 30 days to purchase up to an additional 5,400,000 shares of common stock to cover overallotments, if any.
Phoenix New Media (NYSE: FENG) 1.6% HIGHER; reported Q1 EPS of ($1.97. Revenue for the quarter came in at $26.2 million. For the second quarter of 2011, the Company expects its net advertising revenues to be between RMB110 million to RMB112 million, which represents growth of approximately 142% to 146% from the second quarter of 2010. Paid service revenues are expected to be between RMB106 million to RMB109 million, which represents 35% to 39% growth from the second quarter of 2010. As a result, total revenues are expected to be between RMB216 million to RMB221 million, which represents 74% to 78% growth, approximately, from the second quarter of 2010.
Check out our After-Hours Movers entity page to track this report each day.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON
- Barclays flags an "attractive entry point" in this pharma stock
- Off-price retailers poised for strong second-quarter results as margin gains build
Create E-mail Alert Related Categories
Special ReportsRelated Entities
After-Hours MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
